Women's Health
What Is a Normal Cholesterol Level in PCOS?
Women with PCOS are two to three times more likely to have an abnormal lipid profile than women without the condition — even when their total cholesterol looks fine on paper. Understanding what 'normal' really means for your labs, and why PCOS shifts those goalposts, is one of the highest-leverage things you can do for long-term cardiovascular health.
What Is a Normal Cholesterol Level in PCOS?
For most women with PCOS, standard cholesterol reference ranges still apply — but "in range" does not mean "optimal." The key caveat is that PCOS drives a dyslipidemia pattern (low HDL, elevated triglycerides, and small dense LDL particles) that conventional lipid panels often miss. Women with PCOS who appear to have normal total cholesterol may still carry meaningfully elevated cardiovascular risk, which is why interpreting each component separately matters more than the headline number.
---
Why PCOS Changes Your Lipid Picture
Polycystic ovary syndrome is not just a reproductive condition. It is fundamentally a metabolic disorder driven by insulin resistance and androgen excess — two forces that directly disrupt lipid metabolism. Insulin resistance suppresses hepatic production of large, buoyant HDL particles while stimulating VLDL synthesis, which raises triglycerides and drives the formation of small, dense LDL (sdLDL) — the most atherogenic LDL subtype. Elevated androgens compound this by further reducing HDL-C concentrations.
A large meta-analysis of 30 studies found that women with PCOS had significantly lower HDL cholesterol, higher LDL cholesterol, higher triglycerides, and higher total cholesterol compared to controls matched for body weight (Palomba et al., Human Reproduction Update 2015; PMID: 25538308). Critically, these differences persisted even in lean women with PCOS, which means body weight alone does not explain the pattern.
This matters when reading your labs. A total cholesterol of 185 mg/dL might appear reassuring, but if your HDL sits at 42 mg/dL and your triglycerides are 160 mg/dL, the clinical picture is very different from a woman with the same total cholesterol but an HDL of 68 mg/dL and triglycerides of 75 mg/dL. Understanding what causes total cholesterol to be out of range requires looking beyond the single number.
---
Total Cholesterol Normal Range by Age — and What It Means in PCOS
General population reference ranges for total cholesterol are broadly consistent across adult life until menopause, after which total cholesterol tends to rise in women.
| Age Group | Desirable Total Cholesterol | Borderline High | High |
|---|---|---|---|
| 20–39 years | < 170 mg/dL (optimal) / < 200 mg/dL (acceptable) | 200–239 mg/dL | ≥ 240 mg/dL |
| 40–59 years | < 200 mg/dL | 200–239 mg/dL | ≥ 240 mg/dL |
| 60+ years | < 200 mg/dL | 200–239 mg/dL | ≥ 240 mg/dL |
Source: American Heart Association / ACC 2019 Cardiovascular Risk Guidelines.
For women with PCOS, a total cholesterol under 200 mg/dL should not be used as a standalone reassurance. Because the PCOS dyslipidemia pattern is characterized by relatively normal total cholesterol with an unfavorable distribution of its components — particularly low HDL and elevated triglycerides — the cholesterol ratio (total cholesterol ÷ HDL) and non-HDL cholesterol (total minus HDL) are more informative markers. The AHA considers a total-to-HDL ratio below 3.5 optimal for women.
If your total cholesterol is borderline, understanding why your total cholesterol is borderline requires a full lipid fractionation, not just a repeat of the same panel.
---
LDL Cholesterol Normal Range by Age in Women with PCOS
LDL remains the primary target of cardiovascular risk management guidelines, but PCOS adds an important layer of complexity: LDL particle size and number, not just LDL mass, drive atherogenicity.
| Risk Category | Optimal LDL | Near Optimal | Borderline High | High |
|---|---|---|---|---|
| Low cardiovascular risk | < 100 mg/dL (optimal) | 100–129 mg/dL | 130–159 mg/dL | ≥ 160 mg/dL |
| Moderate risk (many women with PCOS) | < 100 mg/dL | 100–129 mg/dL | 130–159 mg/dL | ≥ 160 mg/dL |
| High risk (PCOS + metabolic syndrome or T2D) | < 70 mg/dL | — | ≥ 70 mg/dL | — |
Based on ACC/AHA 2018 Cholesterol Guidelines.
Women with PCOS and insulin resistance tend to produce a higher proportion of sdLDL particles at any given LDL-C level. A standard LDL of 115 mg/dL in a woman with PCOS and elevated insulin may represent more cardiovascular risk than the same number in a metabolically healthy woman, because the sdLDL fraction is more likely to penetrate arterial walls and oxidize. This is why functional practitioners often pair LDL-C with ApoB or LDL-P (particle number) testing for women with PCOS.
For a thorough grounding in how LDL ranges are interpreted across the risk spectrum, the guide to what is a normal LDL level provides a useful reference framework.
From a lifestyle and supplement standpoint, research on supplements that lower total cholesterol identifies several clinically validated options — with dietary fiber, plant sterols, and omega-3 fatty acids having the strongest evidence for LDL reduction.
---
HDL Cholesterol Normal Range by Age in PCOS
HDL is arguably the most clinically significant cholesterol fraction for women with PCOS. Low HDL is both a diagnostic feature of metabolic syndrome and one of the most consistent lipid abnormalities seen in PCOS cohorts.
| Age Group | Optimal HDL (Women) | Acceptable | Low (High Risk) |
|---|---|---|---|
| 20–39 years | ≥ 60 mg/dL | 50–59 mg/dL | < 50 mg/dL |
| 40–59 years | ≥ 60 mg/dL | 50–59 mg/dL | < 50 mg/dL |
| 60+ years | ≥ 60 mg/dL | 50–59 mg/dL | < 50 mg/dL |
Note: The female-specific threshold for low HDL is < 50 mg/dL (versus < 40 mg/dL in men), per ATP III and AHA criteria.
In the Palomba et al. meta-analysis cited above, women with PCOS had mean HDL levels approximately 6 mg/dL lower than matched controls — a difference that translates to a clinically meaningful increase in cardiovascular event risk over decades. A separate prospective analysis published in the Journal of Clinical Endocrinology & Metabolism found that insulin resistance mediated roughly 60% of the HDL reduction observed in PCOS, reinforcing that improving insulin sensitivity is the most direct lever for raising HDL in this population (Diamanti-Kandarakis & Dunaif, JCEM 2012; PMID: 22563018).
For a detailed breakdown of what HDL numbers mean across the risk continuum, what is a normal HDL level walks through both conventional and functional-medicine interpretations.
Lifestyle interventions with the strongest HDL-raising evidence in PCOS include: aerobic exercise (150+ minutes/week), Mediterranean-pattern diet, and correction of vitamin D deficiency — the latter of which leads directly into the next section.
---
Vitamin D Level Normal Range by Age — and Its Connection to PCOS Lipids
Vitamin D deficiency is extraordinarily common in PCOS. Studies estimate that 67–85% of women with PCOS have suboptimal vitamin D status (< 30 ng/mL), compared to roughly 40–50% of the general female population (Fatemi Zadeh et al., Gynecological Endocrinology 2019). This matters for cholesterol because vitamin D receptors are expressed in key tissues governing lipid metabolism, including the liver and adipose tissue.
Clinical reference ranges for 25-hydroxyvitamin D:
| Status | Serum 25(OH)D Level |
|---|---|
| Deficient | < 20 ng/mL |
| Insufficient | 20–29 ng/mL |
| Sufficient | 30–50 ng/mL |
| Optimal (functional) | 40–60 ng/mL |
| Potentially excessive | > 100 ng/mL |
A randomized controlled trial in 60 PCOS patients found that vitamin D3 supplementation (50,000 IU biweekly for 8 weeks) significantly reduced total cholesterol, LDL, and triglycerides while increasing HDL, compared to placebo — with corresponding improvements in insulin resistance markers (Mehranfar et al., International Journal of Reproductive BioMedicine 2019; PMID: 31435584). A meta-analysis of 9 RCTs further confirmed that vitamin D supplementation in PCOS significantly improved fasting glucose and insulin sensitivity, which secondarily benefits the lipid profile (Miao et al., Nutrition Research 2020; PMID: 32065940).
Age does not dramatically shift vitamin D targets, but absorption efficiency declines with age and sun exposure requirements increase — making supplementation increasingly important for women with PCOS in their 30s and 40s.
---
Triglycerides: The Overlooked PCOS Lipid Marker
While LDL attracts the most clinical attention, elevated triglycerides may be the most characteristic lipid abnormality in PCOS. Triglycerides above 150 mg/dL are classified as borderline high; above 200 mg/dL is high. In PCOS, insulin resistance drives overproduction of VLDL by the liver, directly raising triglyceride output.
The PCOS-specific triglyceride concern is compounded by the fact that high triglycerides simultaneously suppress HDL production and promote sdLDL formation — creating a three-way dyslipidemia (high TG + low HDL + elevated sdLDL) that standard total cholesterol numbers completely obscure. Women with PCOS and triglycerides above 130 mg/dL should request a full lipid fractionation or an ApoB measurement, even if their LDL-C and total cholesterol appear normal.
Omega-3 fatty acids (EPA + DHA at doses ≥ 2g/day) have the most robust evidence for triglyceride reduction, with high-dose omega-3 supplementation lowering triglycerides by 20–30% in multiple RCTs (Skulas-Ray et al., Circulation 2019; PMID: 31422671).
---
What This Means for Your Formula
For women with PCOS navigating an unfavorable lipid profile, targeted supplementation can meaningfully complement dietary and lifestyle changes — but the ingredients that matter most depend on which specific lipid abnormalities are present.
Ones addresses this through AI-driven analysis of uploaded lab results, building a personalized capsule formula calibrated to your specific findings rather than a generic women's health stack.
Omega-3 (EPA/DHA): Ones includes pharmaceutical-grade omega-3s dosed to clinical ranges for triglyceride support. The evidence base for EPA/DHA in PCOS-associated hypertriglyceridemia is among the strongest in the supplement literature, with effect sizes of 20–30% TG reduction at ≥ 2g/day (Skulas-Ray et al., 2019).
Vitamin D3 + K2 (MK-7): Given the 67–85% prevalence of vitamin D insufficiency in PCOS and its direct effects on insulin sensitivity and the lipid profile, vitamin D3 is one of the most evidence-supported additions to a PCOS formula. Ones pairs D3 with K2 (MK-7) to support calcium partitioning — relevant for cardiovascular health in women managing hormonal imbalance. Dosing is personalized based on your serum 25(OH)D results.
Endocrine Support (System Blend): Ones' proprietary Endocrine Support blend is designed for hormonal and metabolic balance, addressing the upstream insulin resistance and androgen excess that drive PCOS-related dyslipidemia. Because the lipid abnormalities in PCOS are fundamentally secondary to these hormonal and metabolic disturbances, addressing root-cause mechanisms — not just downstream lipid numbers — is the more sustainable approach.
When you upload your labs to Ones, the AI health practitioner identifies which components of your lipid panel are most out of range relative to your PCOS status and calibrates your daily formula accordingly, selecting ingredients from the clinically validated catalog at doses shown to be effective in peer-reviewed trials.
---
Key Takeaways
- Total cholesterol alone is not a reliable metric in PCOS. Women with PCOS can have normal total cholesterol while carrying significant cardiovascular risk due to low HDL, high triglycerides, and elevated small dense LDL.
- Optimal HDL for women is ≥ 60 mg/dL; an HDL below 50 mg/dL is the female-specific threshold for high risk and is disproportionately common in PCOS due to insulin resistance and androgen excess.
- LDL targets depend on your overall cardiovascular risk profile, but women with PCOS and metabolic syndrome or prediabetes should aim for LDL < 100 mg/dL — and may benefit from LDL particle testing (ApoB or LDL-P) rather than relying on LDL-C alone.
- Vitamin D deficiency is present in up to 85% of women with PCOS and independently worsens insulin resistance, which in turn degrades every lipid marker. RCTs show that correcting vitamin D status improves total cholesterol, LDL, HDL, and triglycerides.
- Triglycerides are a key PCOS marker often overlooked when total cholesterol looks normal. Omega-3 supplementation at ≥ 2g EPA/DHA daily has the strongest evidence for triglyceride reduction in this population.
- Personalized supplementation that targets your specific lab pattern — rather than a generic multivitamin — is the most evidence-aligned approach for managing PCOS-related dyslipidemia. Consulting a healthcare provider for medical decisions remains essential.